Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished ...
Glioblastoma typically kills within 18 months, but a new type of treatment has kept Nadya El-Afandi's scans clear 17 months ...
Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics ...
Memorial Sloan Kettering Cancer Center-led researchers have identified a small molecule called gliocidin that kills ...
Judi Califano, the mother of WPBF reporter Caleb Califano, has been a lifelong runner, completing three full marathons and seven half marathons.
The Global Coalition for Adaptive Research (GCAR) has executed an agreement to evaluate AstraZeneca's AZD1390 compound in the ...
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies ...
Glioblastoma is the deadliest form of brain cancer, with less than a 5% five-year survival rate. One of the key contributors to glioblastoma’s poor outlook is its natural immunosuppression coupled ...